References
- Adler T. K. The comparative potencies of codeine and its demethylated metabolites after intraventricular injection in the mouse. Journal of Pharmacology and Experimental Therapeutics 1963; 140: 155–161
- Adler T. K. Morphine tolerance in mice I. In vivo N-demethylation of morphine and N- and O- demethylation of codeine. Journal of Pharmacology and Experimental Therapeutics 1967; 156: 585–590
- Adler T. K., Fujimoto J. M., Way E. L., Baker E. M. Metabolic fate of codeine in man. Journal of Pharmacological and Experimental Therapeutics 1955; 114: 251–262
- Axelrod J. Enzymatic conversion of codeine to morphine. Journal of Pharmacology and Experimental Therapeutics 1955 a; 115: 259–267
- Axelrod J. The enzymic N-demethylation of narcotic drugs. Journal of Pharmacology and Experimental Therapeutics 1955 b; 117: 322–330
- Misra A. L. Disposition and metabolism of drugs,. Chemical and Biological Aspects of Drug Dependence, S. J. Mulé, H. Brill. CRC Press, Cleveland 1972; 219–276
- Nebert D. W., Gonzalez F. J. P450 genes: structure, evolution, and regulation,. Annual Review of Biochemistry 1987; 56: 945–993
- Oberst F. W. Relationship of the chemical structure of morphine derivatives to their urinary excretion in free and bound forms. Journal of Pharmacology and Experimental Therapeutics 1941; 73: 401–404
- Oguri K., Yoshimura H., Tsukamoto H. On the structure of morphine-6-glucuronide in a solid state. Chemical and Pharmaceutical Bulletin 1970; 18: 209–210
- Oguri K., Yamada-Mori I., Shigezane J., Hirano T., Yoshimura H. Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position. Life Sciences 1987; 41: 1457–1464
- Osborne R. J., Joel S. P., Slevin K. L. Morphine intoxication in renal failure: The role of morphine-6-glucuronide. British Medical Journal 1986; 292: 1548–1549
- Osborne R. J., Joel S. P., Trew D., Slevin K. L. Analgesic activity of morphine-6-glucuronide. Lancet 1988; 1(589)828
- Scrafani J. T., Clouet D. H. Biotransformation. Narcotic Drugs, Biochemical Pharmacology, D. H. Clouet. Plenum Press, New York 1971; 137–158
- Shimomura K., Kamata O., Ueki S., Ida S., Oguri K., Yoshimura H., Tsukamoto H. Analgesic effect of morphine glucuronides. Tohoku Journal of Experimental Medicine 1971; 105: 45–52
- Svensson J., Rane A., Säwe J., Sjöqvist F. Determination of morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. Journal of Chromatography 1982; 230: 427–432
- Way E. L., Adler T. K. The Biological Disposition of Morphine and Its Surrogates. World Health Organization, Geneva 1962; 35–47
- Woods L. A., Mehlenbeck H. E., Mellett L. B. Plasma level and excretion of codeine and metabolites in the dog and monkey. Journal of Pharmacological and Experimental Therapeutics 1956; 117: 117–125
- Yeh S. Y., Woods L. A. Physiologic disposition of N-14C-methyl-codeine in the rat. Journal of Pharmacology and Experimental Therapeutics 1969; 166: 86–95
- Yeh S. Y., Woods L. A. Isolation of morphine-3-glucuronide from urine and bile of rats injected with codeine. Journal of Pharmacology and Experimental Therapeutics 1970 a; 175: 69–74
- Yeh S. Y., Woods L. A. Isolation and characterization of codeine-6-glucuronide from dog urine. Journal of Pharmacology and Experimental Therapeutics 1970 b; 173: 21–25
- Yoshimura H., Oguri K., Tsukamoto H. The synthesis of codeine and morphine glucuronides. Tetrahedron Letters 1968 a; 4: 483–486
- Yoshimura H., Oguri K., Tsukamoto H. The synthesis of codeine and morphine glucuronides. Chemical and Pharmaceutical Bulletin 1968 b; 16: 2114–2119
- Yoshimura H., Mori M., Oguri K., Tsukamoto H. Studies on the urinary conjugated metabolites of codeine. Biochemical Pharmacology 1970; 19: 2353–2360